Advertisements


Why Celldex Therapeutics Is Getting Crushed

Celldex Therapeutics shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study......»»

Category: blogSource: 247wallstApr 16th, 2018

Why Ovid Therapeutics Is Monday’s Big Biotech Loser

Ovid Therapeutics shares were crushed to start the week even though the company announced positive midstage results for its Angelman syndrome study......»»

Category: blogSource: 247wallstAug 6th, 2018

Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics

Which beaten-down biotech stock wins in a head-to-head match-up?.....»»

Category: topSource: foxnewsJun 29th, 2018

Why Summit Therapeutics Was Crushed

Summit Therapeutics is another biopharma company that is paying the price on Wednesday......»»

Category: blogSource: 247wallstJun 27th, 2018

Celldex Therapeutics Salvage Value

Celldex Therapeutics Salvage Value.....»»

Category: topSource: seekingalphaJun 15th, 2018

Celldex Therapeutics (CLDX) Down 9.2% Since Earnings Report: Can It Rebound?

Zacks.....»»

Category: topSource: redinewsJun 11th, 2018

Why Melinta Therapeutics Shares Are Getting Crushed

Melinta Therapeutics saw its shares plunge on Thursday after the firm announced that it had priced a secondary offering......»»

Category: blogSource: 247wallstMay 24th, 2018

What"s in Store for Celldex (CLDX) This Earnings Season?

With no approved product in Celldex Therapeutics' (CLDX) portfolio, investor focus is on i.....»»

Category: personnelSource: nytMay 3rd, 2018

MGIC, Juniper Networks Slide into Wednesday’s 52-Week Low Club

MGIC Investment Group, Celldex Therapeutics, Juniper Networks, and Healthcare Services Group all posted new 52-week lows on Wednesday......»»

Category: blogSource: 247wallstApr 18th, 2018

Celldex"s Phase II Breast Cancer Study Fails, Shares Plunge

Celldex Therapeutics' (CLDX) glembatumumab vedotin fails to meet primary endpoint in phase IIb METRIC study in metastat.....»»

Category: smallbizSource: nytApr 17th, 2018

Celldex, Acacia Plummet into Monday’s 52-Week Low Club

Celldex Therapeutics, Acacia Communications, Apricus Biosciences, and Ctrp.com all posted new 52-week lows Monday......»»

Category: blogSource: 247wallstApr 16th, 2018

Celldex"s stock plummets toward record low after failed drug study

Shares of Celldex Therapeutics Inc. plummeted 40% in premarket trade Monday toward a record low, after the drug.....»»

Category: topSource: marketwatchApr 16th, 2018

Hedge Funds Are Buying PTC Therapeutics, Inc. (PTCT)

How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded comp.....»»

Category: topSource: insidermonkey3 hr. 31 min. ago

Boston startup nabs U.S. approval for app to help treat opioid addicts

The FDA's clearance of the reSET-O app by Pear Therapeutics marks the first time the federal agency has approved a drug-paired digital device to treat a disease......»»

Category: topSource: bizjournals6 hr. 31 min. ago

Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $295,800 of Shares

Related Stocks: ODT,.....»»

Category: blogSource: gurufocus9 hr. 16 min. ago

Y-mAbs Therapeutics humanized bispecific GD2 antibody IND receives FDA clearance

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall10 hr. 31 min. ago

Armistice Capital reports 6.5% passive stake in Ovid Therapeutics

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall11 hr. 31 min. ago

Celldex announces resignation of board chairman Gerald McMahon

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall11 hr. 31 min. ago

Novartis reports Sandoz, Pear Therapeutics get FDA clearance for reSET-O

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall11 hr. 31 min. ago

JMP boosts Marinus target to $29, sees "clear" competitor to Sage Therapeutics

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall13 hr. 16 min. ago

Here"s Why Crispr Therapeutics Rose 17% in November

The gene-editing pioneer reported third-quarter 2018 earnings and solid progress in the clinic......»»

Category: topSource: foxnews14 hr. 16 min. ago